生前和新生儿管理的兄弟姐妹与碳酸无酶VA缺乏
Sophie Manoy1,2, Tahlee Minto1, Kalliope Demetriou1
1Queensland Lifespan Metabolic Medicine Service, Queensland Children's Hospital Brisbane Australia.
JIMD reports
|February 25, 2026
概括
碳酸无水酶VA (CAVA) 缺乏症是一种罕见的代谢障碍. 产前诊断和早期干预,包括营养和 carglumic 酸,可以预防严重的新生儿并发症在受影响的婴儿.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 儿科 儿科 儿科
背景情况:
- 碳酸无水酶VA (CAVA) 缺乏 (OMIM 114761) 是一种极为罕见的新陈代谢先天性错误.
- 受影响的婴儿呈现出严重的新生儿症状,包括高氨血症,乳酸性酸和脑病变.
研究的目的:
- 描述两名在产前被诊断为CAVA缺乏症的兄弟婴儿的临床过程.
- 证明主动临床管理在预防代谢失补偿方面的有效性.
主要方法:
- 在两个兄弟婴儿的CAVA缺乏症的产前诊断.
- 通过定期养,补充营养和卡格卢米酸进行管理.
- 定期对酸状态和氨水平进行生化监测.
主要成果:
- 产前诊断的兄弟婴儿在没有代谢去补偿的情况下得到管理.
- 他们的新生儿期并不显著,与他们的大兄弟姐妹的严重表现形成鲜明对比.
- 早期干预成功地将与CAVA缺乏相关的风险降到最低.
结论:
- 在产前诊断CAVA缺乏,使主动管理.
- 早期干预策略可以预防患病的婴儿出现严重的新生儿并发症.
- 这种方法尽量减少新生儿期代谢失补偿的风险.
相关概念视频
Acute Respiratory Failure-V
551
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
551
Acute Respiratory Failure-III
1000
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1000
Cystic Fibrosis: Management
580
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
580
Disorders of Acid-Base Balance
2.2K
The human body maintains a precise pH range of arterial blood between 7.35 and 7.45. Deviations result in either acidosis (pH < 7.35) or alkalosis (pH > 7.45). These conditions are further classified as respiratory or metabolic disorders based on their underlying cause.
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
2.2K
Renal Regulation of Acid-Base Balance
2.0K
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
2.0K
Acute Kidney Injury VI: Nursing Management
550
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
550


